Combination of JAK2 and HSP90 inhibitors: an effective therapeutic option in drug-resistant chronic myelogenous leukemia. [electronic resource]
Producer: 20160823Description: 201-208 p. digitalISSN:- 1947-6019
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.